Exhibit 99.1
NANOPHASE ACHIEVES RECORD FIRST QUARTER REVENUE
Romeoville, IL, April 24, 2008–Nanophase Technologies (Nasdaq: NANX), a leader in nanomaterials and advanced nanoengineered products, announced that for the quarter ending March 31, 2008, total revenue was $3.05 million compared to $2.9 million in the first quarter of 2007. Gross margin as a percentage of revenue increased to 35%, versus 25% in the first quarter of 2007, while gross margin dollars increased 48%.
Nanophase continues to narrow its losses with increasing revenues and gross margin growth. Nanophase reported a net loss of $950,000, or $0.04/share, versus a net loss of $1.2 million, or $0.06 per share, in the first quarter of 2007. Management noted that of the $950,000 loss, approximately 71%, or $670,000, was due to non-cash items.
“Nanophase delivered another solid quarter, especially in a difficult economic environment,” noted Joseph Cross, Nanophase’s president and CEO. “In spite of some general and specific market caution entering 2008, comparing the first quarter of 2008 to the prior year, we experienced relatively solid customer demand in personal care and sunscreens, an 82% increase in architectural coatings revenues, twenty-five fold revenue growth in chemical/mechanical planarization nanomaterials, and 37% growth in biosensor nanomaterials. The Company’s revenue declined 26% for industrial coatings and plastics, primarily, we believe, reflecting one customer’s inventory build in the first and second quarter of 2007 that was not duplicated during the first quarter of 2008. We anticipate that industrial coatings and plastics revenues should improve over the next three quarters.”
Cross added: “As we have stated before, our business model requires developing unique value-added solutions that are ready to integrate into customers’ products and, therefore, command higher margins. We believe Nanophase’s consistent margin growth since 2005 has demonstrated that our model and market tactics are having positive effects. Our gross margin this past quarter continues that trend.”
“Operationally, Nanophase continues to perform at a high level with 100% on-time delivery and absolutely zero customer returns in the first quarter. The Company also ended the first quarter with over 875,000 hours, or over 420 man years, worked without a lost time accident – a quite exemplary record for a company of our size.”
Markets and Outlook
Cross noted that while first quarter revenue was encouraging, the Company continues to have limited visibility and is maintaining its 5 to 15% revenue growth estimate for 2008. “Using our improved market development and sales approach, we have made sound progress adding targeted new revenue opportunities to our stage gate sales process. While we continue to work closely with our market partners, we have been developing a greater in-house ability to directly market new nanomaterial-based solutions. To further that effort, we increased our sales staff this past quarter with the addition of an experienced chemical sales professional to expand targeted customer initiatives.”
“But, it remains pragmatically difficult for us to accurately forecast the speed of movement through the stage gates, the start of revenue generating activities, and the ensuing growth ramp,” Cross noted. “At this point, we anticipate that second quarter 2008 revenue will be relatively flat with the current quarter. We do not believe that the inventory build-up from two major customers that benefited the second quarter of 2007 will recur in 2008.”
Cross noted that the Company finished the first quarter with $16 million in cash and equivalents and should be adequately capitalized to meet its growth objectives in the foreseeable future. Nanophase believes that it has adequate facilities and equipment to support a $20-25 million revenue run rate, depending on product mix, and does not anticipate material capital spending during 2008.
Cross concluded: “We continue to expect an increased revenue run rate in the second half of 2008 based on market partner forecasts and opportunities that we are pursuing. As we see how the second quarter unfolds and have increased information on new opportunities, we will re-evaluate our 2008 outlook at the appropriate time.”
Nanophase has scheduled its quarterly conference call for April 24, 2008 at 4:00PM CDT (5:00PM EDT), which will be hosted by Joseph Cross, president and CEO, and Jess Jankowski, CFO. The call may be accessed through the Company’s website,www.nanophase.com, by clicking on the link under Investor Relations and Calendar of Events. If you are unable to attend, a replay will be available through May 1, 2008 by dialing 706-645-9291 and entering code 44233587, or by logging onto the Company’s website and following the above directions.
Nanophase Technologies Corporation (NANX),www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company owns or licenses 18 United States and 49 foreign patents and patent applications. Information about Nanophase may be found in the Company’s public filings or on its website.
This press release contains words such as “expects”, “shall”, “will” , “believes” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risk and uncertainties include the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s nanocrystalline materials; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; and other risks described in the Company’s Form 10K filed March 14, 2007, and other filings with the Securities and Exchange Commission. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.
NANOPHASE TECHNOLOGIES CORPORATION
BALANCE SHEETS
(Unaudited)
March 31, 2008 | December 31, 2007 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 1,234,033 | $ | 563,075 | ||||
Investments | 14,808,624 | 16,145,844 | ||||||
Trade accounts receivable, less allowance for doubtful accounts of $13,000 on March 31, 2008 and December 31, 2007 | 1,982,630 | 1,403,206 | ||||||
Inventories, net | 1,129,825 | 1,085,364 | ||||||
Prepaid expenses and other current assets | 373,838 | 298,464 | ||||||
Total current assets | 19,528,950 | 19,495,953 | ||||||
Equipment and leasehold improvements, net | 7,226,314 | 7,409,666 | ||||||
Other assets, net | 624,108 | 781,266 | ||||||
$ | 27,379,372 | $ | 27,686,885 | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Current portion of capital lease obligations | $ | 44,092 | $ | 43,110 | ||||
Current portion of deferred other revenue | 127,273 | 127,273 | ||||||
Accounts payable | 802,443 | 238,295 | ||||||
Accrued expenses | 1,459,725 | 1,584,656 | ||||||
Total current liabilities | 2,433,533 | 1,993,334 | ||||||
Long-term debt, less current maturities and unamortized debt discount | 1,526,524 | 1,512,507 | ||||||
Long-term portion of capital lease obligations | 20,032 | 31,430 | ||||||
Deferred other revenue, less current portion | 42,425 | 74,243 | ||||||
1,588,981 | 1,618,180 | |||||||
Contingent liabilities: | — | — | ||||||
Stockholders’ equity: | ||||||||
Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding | — | — | ||||||
Common stock, $.01 par value, 30,000,000 shares authorized; 21,116,369 and 21,088,068 shares issued and outstanding on March 31, 2008 and December 31, 2007, respectively | 211,164 | 210,881 | ||||||
Additional paid-in capital | 90,430,162 | 90,201,131 | ||||||
Accumulated deficit | (67,284,468 | ) | (66,336,641 | ) | ||||
Total stockholders’ equity | 23,356,858 | 24,075,371 | ||||||
$ | 27,379,372 | $ | 27,686,885 | |||||
NANOPHASE TECHNOLOGIES CORPORATION
STATEMENTS OF OPERATIONS
(Unaudited)
Three months ended March 31, | ||||||||
2008 | 2007 | |||||||
Revenue: | ||||||||
Product revenue | $ | 2,942,722 | $ | 2,794,141 | ||||
Other revenue | 111,386 | 112,296 | ||||||
Total revenue | 3,054,108 | 2,906,437 | ||||||
Operating expense: | ||||||||
Cost of revenue | 2,000,208 | 2,193,275 | ||||||
Gross Profit | 1,053,900 | 713,162 | ||||||
Research and development expense | 438,695 | 524,164 | ||||||
Selling, general and administrative expense | 1,694,068 | 1,410,259 | ||||||
Loss from operations | (1,078,863 | ) | (1,221,261 | ) | ||||
Interest income | 167,221 | 99,626 | ||||||
Interest expense | (38,416 | ) | (33,047 | ) | ||||
Other, net | 2,231 | (69,345 | ) | |||||
Loss before provision for income taxes | (947,827 | ) | (1,224,027 | ) | ||||
Provision for income taxes | — | — | ||||||
Net loss | $ | (947,827 | ) | $ | (1,224,027 | ) | ||
Net loss per share-basic and diluted | $ | (0.04 | ) | $ | (0.06 | ) | ||
Weighted average number of basic and diluted common shares outstanding | 21,106,607 | 19,005,846 | ||||||
NANOPHASE TECHNOLOGIES CORPORATION
STATEMENTS OF OPERATIONS—EXPANDED SCHEDULE
(Unaudited)
Three months ended March 31 | ||||||||
2008 | 2007 | |||||||
Revenue: | ||||||||
Product revenue, net | $ | 2,942,722 | $ | 2,794,141 | ||||
Other revenue | 111,386 | 112,296 | ||||||
Total revenue | 3,054,108 | 2,906,437 | ||||||
Operating expense: | ||||||||
Cost of revenue detail: | ||||||||
Depreciation | 238,044 | 280,080 | ||||||
Non-Cash equity compensation | 16,771 | 14,402 | ||||||
Other costs of revenue | 1,745,393 | 1,898,793 | ||||||
Cost of revenue | 2,000,208 | 2,193,275 | ||||||
Gross profit | 1,053,900 | 713,162 | ||||||
Research and development expense detail: | ||||||||
Depreciation | 58,458 | 55,362 | ||||||
Non-Cash equity compensation | 31,032 | 45,230 | ||||||
Other research and development expense | 349,205 | 423,572 | ||||||
Research and development expense | 438,695 | 524,164 | ||||||
Selling, general and administrative expense detail: | ||||||||
Depreciation and amortization | 24,094 | 19,098 | ||||||
Non-Cash equity compensation | 152,660 | 146,704 | ||||||
Patent abandonment charge | 168,050 | — | ||||||
Other selling, general and administrative expense | 1,349,264 | 1,244,457 | ||||||
Selling, general and administrative expense | 1,694,068 | 1,410,259 | ||||||
Loss from operations | (1,078,863 | ) | (1,221,261 | ) | ||||
Interest income | 167,221 | 99,626 | ||||||
Interest expense | (38,416 | ) | (33,047 | ) | ||||
Other, net | 2,231 | (69,345 | ) | |||||
Loss before provision for income taxes | (947,827 | ) | (1,224,027 | ) | ||||
Provision for income taxes | — | — | ||||||
Net loss | $ | (947,827 | ) | $ | (1,224,027 | ) | ||